Cash and equivalents fell to $803.9M
Company: Core Scientific
The claim, verbatim
Cash and cash equivalents fell to $803.9 million from $1.77 billion in Q2.
Source (primary)
Core Scientific Q3 2026 Earnings: Colocation Scale Drives Margin Expansion - TradingKey (-, news_article)
View cached copy (2026-11-06)Live source ↗Archive.org ↗
Quote: “Cash and cash equivalents fell to $803.9 million from $1.77 billion over the same period”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific Q3 2026 Earnings: Colocation Scale Drives Margin Expansion - TradingKey
Quote: “Cash and cash equivalents fell to $803.9 million from $1.77 billion over the same period”